Table 1.
List of CXCR4 Inhibitors
Name of CXCR4 Inhibitors or Analog Designation |
Molecular Type | Amino Acid Sequences, Modification Diagrams, or Chemical Structures |
Biological Activities | Stage of Development |
References |
---|---|---|---|---|---|
1 | d-Peptide | Ac-NH-(d-Arg)9-COOH | Block HIV-1 entry | Phage I | 53,72,73 |
AMD3100 | Small Orgnic Molecule |
![]() |
(1) Block HIV-1 entry; (2) promote stem cell migration; (3) inhibit stromal–leukemia cell interactions; and (4) anti-RA and allergic asthma activities |
Approved in 2008 for patients with lymphoma and multiple myeloma as a source of hematopoietic stem cells for transplantation |
57, 200,111, 117,113,125 |
2 | Small Orgnic Molecule |
![]() |
CXCR4 Antagonist | Pre-clinical | 77 |
AMD3465 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Pre-clinical | 78 |
3 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Phase I | 80 |
4 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Phase I | 84 |
5 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Pre-clinical | 85,86 |
6 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Pre-clinical | 87 |
T22 | Peptide |
![]() |
(1) Block HIV-1 entry; and (2) anti-RA activities |
Pre-clinical | 58 |
T140 | Peptide |
![]() |
(1) Block HIV-1 entry; (2) promote stem cell migration; and (3) anti-RA activities |
Pre-clinical | 88,89,201 |
TC14012 | Peptide |
![]() |
Block HIV-1 entry | Pre-clinical | 88 |
7 | Peptide |
![]() |
(1) Block HIV-1 entry; and (2) anti-RA activities |
Pre-clinical | 89 |
8 | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Pre-clinical | 93 |
R3G | Small Orgnic Molecule |
![]() |
Block HIV-1 entry | Pre-clinical | 203 |
SDF-1α | Peptide |
![]() KPVSLSYRCPCRFFESHVARANVK HLKILNTPNCALQIVARLKNNNRQ VCIDPKLKWIQEYLEKALNK |
Block HIV-1 entry | Pre-clinical | 59,60,67,69 |
CTCE-9908 | Peptide | KGVSLSYRKRYSLSVGK | Inhibit cancer growth and metastases |
Phase II | 128-130 |
vMIP-II | Peptide |
![]() LGASWHRPDKCCLGYQKRPLPQV LLSSWYPTSQLCSKPGVIFLTKRGR QVCADKSKDWVKKLMQQLPVTA R |
Block HIV-1 entry | Pre-clinical | 19,20 |
V1 | Peptide |
![]() LGASWHRPDKCCLGYQ KRPLP |
Block HIV-1 entry | Pre-clinical | 61 |
DV1 | d-Peptide |
![]() LGASWHRPDKCCLGYQ KRPLP |
Block HIV-1 entry | Pre-clinical | 64 |
9 |
d-Amino Acid Containing Peptide |
![]() LGASWHRPDKCCLGYQKRPLPQVL LSSWYPTSQLCSKPGVIFLTKRGR QVCADKSKDWVKKLMQQLPVTA R |
(1) Block HIV-1 entry; and (2) inhibit stromal–leukemia cell interactions |
Pre-clinical | 98,99,124 |
D-amino acids are shown in italic.